Corxel Pharmaceuticals
Clinical trials sponsored by Corxel Pharmaceuticals, explained in plain language.
-
New daily pill for obesity shows promise in early trial
Disease control Recruiting nowThis early-stage trial tests a new daily pill called CX11 in 90 adults with obesity or overweight who also have weight-related health problems like high blood pressure or prediabetes. The study aims to see if the pill is safe and helps with weight loss compared to a placebo. Part…
Phase: PHASE1 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New diabetes drug CX11 shows promise in major trial
Disease control Recruiting nowThis study tests a new medication, CX11, for people with type 2 diabetes who need better blood sugar control despite taking metformin. About 240 adults will receive different doses of CX11 or a placebo for 24 weeks to see if it safely lowers blood sugar. The goal is to find the b…
Phase: PHASE2 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Late-Stroke hope: new drug could help hours after symptoms start
Disease control Recruiting nowThis study tests a drug called JX10 in people who have had a stroke and arrive at the hospital 4.5 to 24 hours later. The goal is to see if JX10 can improve recovery and reduce disability compared to a placebo. About 740 participants will be randomly assigned to receive JX10 or a…
Phase: PHASE2, PHASE3 • Sponsor: Corxel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC